Literature DB >> 9635800

Antibiotic prophylaxis in the initial management of severe acute pancreatitis.

J J Powell1, R Miles, A K Siriwardena.   

Abstract

BACKGROUND: The role of antibiotic prophylaxis in the initial management of patients with acute pancreatitis is an area of major controversy. Contrary to earlier clinical trials, recent experimental and clinical studies have accrued evidence that warrants reappraisal of current clinical practice. This article reviews these recent advances in knowledge.
METHODS: All papers derived from a Medline search for the years 1990-1997 inclusive using the text words 'acute', 'pancreatitis', 'antibiotic' and 'antibiotics' were studied. Additional papers were derived from reference lists within papers identified by the Medline search. Only experimental and clinical papers relevant to the issue of prophylactic antibiotic therapy in acute pancreatitis are included in the review. RESULTS AND
CONCLUSION: Current experimental evidence favours the use of prophylactic antibiotics in severe acute pancreatitis. The results of contemporary randomized clinical trials restricted to patients with prognostically severe acute pancreatitis have demonstrated improvement in outcome associated with antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635800     DOI: 10.1046/j.1365-2168.1998.00767.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference.

Authors:  H G Beger; R Isenmann
Journal:  Int J Pancreatol       Date:  1999-08

Review 2.  Prophylactic antibiotics and pancreatic necrosis.

Authors:  B Gloor; O Schmidt; W Uhl; M W Büchler
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 3.  The role of infection in acute pancreatitis.

Authors:  S W Schmid; W Uhl; H Friess; P Malfertheiner; M W Büchler
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Planned staged reoperative necrosectomy using an abdominal zipper in the treatment of necrotizing pancreatitis.

Authors:  Dejan V Radenkovic; Djordje D Bajec; Gregory G Tsiotos; Aleksandar R Karamarkovic; Natasa M Milic; Branislav D Stefanovic; Vesna Bumbasirevic; Palve M Gregoric; Dragan Masulovic; Miroslav M Milicevic
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 6.  Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.

Authors:  Eduardo Villatoro; Mubashir Mulla; Mike Larvin
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

7.  Acute necrotizing pancreatitis: treatment strategy according to the status of infection.

Authors:  M W Büchler; B Gloor; C A Müller; H Friess; C A Seiler; W Uhl
Journal:  Ann Surg       Date:  2000-11       Impact factor: 12.969

8.  The role of the intestine in the pathophysiology and management of severe acute pancreatitis.

Authors:  R S Flint; J A Windsor
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

9.  The effect of activated protein C on experimental acute necrotizing pancreatitis.

Authors:  Levent Yamanel; Levent Yamenel; Mehmet Refik Mas; Bilgin Comert; Ahmet Turan Isik; Sezai Aydin; Nuket Mas; Salih Deveci; Mustafa Ozyurt; Ilker Tasci; Tahir Unal
Journal:  Crit Care       Date:  2005-03-04       Impact factor: 9.097

10.  Combinatory antibiotic treatment protects against experimental acute pancreatitis by suppressing gut bacterial translocation to pancreas and inhibiting NLRP3 inflammasome pathway.

Authors:  Lingling Jia; Hao Chen; Jun Yang; Xin Fang; Wenying Niu; Ming Zhang; Jiahong Li; Xiaohua Pan; Zhengnan Ren; Jia Sun; Li-Long Pan
Journal:  Innate Immun       Date:  2019-10-15       Impact factor: 2.680

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.